Skip to content

Use of mahanilvarti anjana in the corneal opacity

Study of effect Mahanilavari Anjan in management of Avarana Shukla with special reference to corneal opacity

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029250
Enrollment
40
Registered
2020-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H178- Other corneal scars and opacities

Interventions

Intervention1: Mahanil Varti Anjana: The patients of this group were applied with MahanilaVarti Anjana Dose
1 Vidanga matra frequency
Once a Day (OD) route of administration
In the lower eyelid of affected eye Duration of therapy 15 Days Control Intervention1: CMC E/D: This Group is Control Group The patients of this group were applied with cmc lubricating Drop Dose
1 Drop frequency
Once a Day (OD) route of administration
In the lower eyelid of affected eye Duration of therapy 15 Days

Sponsors

MGACH and RC Salod At post Wardha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of 25-50 years of age were selected irrespective of sex, socioeconomic status and religion 2 The chronicity of the disease less than 5 years. 3 Grade 1 & 2 corneal opacities

Exclusion criteria

Exclusion criteria: 1 Savrana Shukla 5. Grade 3 corneal opacity 2 Associated with diabetes, hypertension malignancy and acute specific infectious systemic disease 3 Contra- indication for Anjana 4 Corneal opacities with other complications like adherent leucoma, corneal facet, kerectasia and anterior staphyloma etc

Design outcomes

Primary

MeasureTime frame
Corneal opacity size, density will be regress or tattooing assessed by ant.OCT and PachymetryTimepoint: 2 Week

Secondary

MeasureTime frame
Corneal opacity size, density will be regress or tattooing assessed by ant.OCT and PachymetryTimepoint: 8 Week

Countries

India

Contacts

Public ContactDr Roshna Sukhdeoji Bhutada Rathi

MGACH and RC Salod At post Wardha

drroshnarathi@gmail.com7588520679

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026